Neural circuits in lung adenocarcinoma modulate immunosurveillance.
2/5 보강
OpenAlex 토픽 ·
Cancer, Stress, Anesthesia, and Immune Response
Vagus Nerve Stimulation Research
Lung Cancer Research Studies
Recent evidence from a study published in Nature by Wei et al.
APA
Kostas A. Papavassiliou, Dimitrios J. Stravopodis, Athanasios G. Papavassiliou (2026). Neural circuits in lung adenocarcinoma modulate immunosurveillance.. Trends in cancer. https://doi.org/10.1016/j.trecan.2026.03.006
MLA
Kostas A. Papavassiliou, et al.. "Neural circuits in lung adenocarcinoma modulate immunosurveillance.." Trends in cancer, 2026.
PMID
41986212 ↗
Abstract 한글 요약
Recent evidence from a study published in Nature by Wei et al. reveals a bidirectional tumor-brain axis in lung cancer that suppresses immune surveillance by reprogramming macrophages and disabling T cell responses. These findings highlight neuroimmune signaling as a key regulator of cancer progression and a promising therapeutic target.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Integrating Tumor Biology into Anatomy: The Future of Lung Cancer Staging.
- Cracking the Code of Immunotherapy Resistance in SCLC: Molecular Insights and Emerging Solutions.
- Biologically Informed Treatment Approaches Toward Personalized Therapeutic Strategies in Lung Cancer.
- Proposal for a Hybrid Anatomical and Biological Staging System in Lung Cancer.
- The potential of tumour mechanotargeting in lung cancer therapeutics.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Combining network pharmacology and experimental validation to study the action and mechanism of brusatol against lung adenocarcinoma.
- Acquired L858R mutation following -TKI resistance in lung adenocarcinoma: a case report.
- NG25 Enhances Anti-Tumor Immunity in -Mutant Colorectal Cancer.
- F2R and MXRA5: the metabolic obesity-derived biomarkers for immunosuppression and poor survival in triple-negative breast cancer.
- Hierarchical Targeting of TREM2 Myeloid Cells via Acid-Triggered OMVs Reprogram Immunosuppression and Suppress Osteolysis in Bone-Metastatic TNBC.
- Efficacy of first-line immunochemotherapy across KRAS mutation subtypes in advanced lung adenocarcinoma.